ICH Guidelines, U. K, and H. l, “DEVELOPMENT AND VALIDATION OF OSIMERTINIB IN TABLET DOSAGE FORM BY RP-HPLC”, IJPAR , vol. 14, no. 4, pp. 1186–1199, Oct. 2025.